Po-718-03 identifying and characterizing patients with atrial fibrillation and elevated thromboembolic risk who are not appropriately anticoagulated

Atrial fibrillation (AF) is the leading cause of stroke, which can be reduced by 70% with appropriate use of anticoagulation therapy. Nationally, appropriate anticoagulation rates for patients with AF with elevated thromboembolic risk are as low as 50% even across the highest CHADS2VASC score cohorts. Understanding anticoagulation fallout rates among gender, ethnicity, and socioeconomic status is an important first step towards decreasing the risk of thromboembolic events.
Source: Heart Rhythm - Category: Cardiology Authors: Source Type: research